BMC Musculoskeletal Disorders

official impact factor 1.94

Open Access

Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study

Guillem Cuatrecasas*, Cristina Riudavets, Maria A Güell and Albert Nadal

BMC Musculoskeletal Disorders 2007, 8:119 doi:10.1186/1471-2474-8-119

Accesses  

  • Last 30 days: 68 accesses
  • Last 365 days: 553 accesses
  • All time: 4478 accesses